U.S. Markets open in 1 hr 32 mins

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
17.35+0.04 (+0.23%)
At close: 4:00PM EDT
People also watch
  • \What left on the investorvillage board?\ Besides a couple of those who show they have no idea of what is transpiring with markets\ There goes another 50k Trade!!! \seemingly spending their lives on 1 stock\so sad\
    Cubbie posts Glass door bulletin board stuff\ There is new jobs! \ So why do those jobs seem to always hang around? \
    BECAUSE THEY ARE CONTINGENT ON THE PHASE3 TRIAL RESULTS\ Hiring of sales people{strongly doubt it}will take a lot of time and cash into 2019\Besides that ZERO of value and those posting MISINFORMATION\LOOKS LIKE INVVILLAGE IN financial trouble with SALE! on membership and dwindling #s\INSM board has 5 real members 3 of whom use multiple identities\ EOS
  • If one does not know a dang thing about trading \one should not say stupid things about money managers or the trading currently and obviously underway with INSM\JAD9000 call this "World class manipulation"\which shows clear ignorance\"We seem to have an MM exercising world class manipulation and pinning of the share price." and shows heshe hasnt any idea about the pending results timeline| " Hopefully they can get the data to the marketplace in the next 30 days or so. IMPOSSIBLE |
    and if all that wasnt stupid enough! "It would absolutely crush the remaining shorts and boost the offering price. " THIS PERSON MUST BE POSTING TO THEMSELVES BECAUSE ANYONE ELSE IS LAUGHING!\
  • Attention : Announced this morning =\the last patient has exited the trial \
  • More and more a dilution feels like its coming although I would prefer a partner or buyout
  • Thanks kinkey
    Needs to be reported we are at least 2 months from results with last patient exiting
    after today and listening I am much more cautious
  • from another poster on another venue I asked about this poster planting "seeds of doubt" he responded that as of now he sees no reason to base his investment on a notoriously inaccurate government site. Insmed will release results aprx 4-6 weeks after the trial is unblinded to glean data and he guesstimates Oct although as early as next month is possible.He continues to profit with swing trades with INSM
  • Thanks Peter. Needs to be reported that scammers are posting phony claims. Always rely on verifiable facts.
  • INSM was almost $29 two years ago.........now about $17........a total disaster!!!! That's a fact morons!
  • \Yesterdays call gave substantive info to develop a timeline on the drugs progress\ dilution and partner possibilities \
    \Inv board shows posters have no knowledge or experience to comment a few below \
  • Newbie Alert!!!!!.....Marchalk is right. He has provided irrefutable evidence in his posts. Just read the facts and examine the proof for yourself. Don't let these boiler room losers steal your money.
  • "Media headlines about Insmed (NASDAQ:INSM) have trended somewhat positive recently, according to Accern Sentiment Analysis". They must have missed the balance sheet remarks.
  • Insmed ended the first quarter of 2017 with approximately $55 million in debt.
  • Today's pump-lines "14 hours ago - Driehaus Capital Management LLC bought a new stake in Insmed" LMAO
  • Volume precedes price. Big move coming, then data release!
  • What does it say that you can sell the October 18 calls for $7.00 when the stock is at $17.00?
  • As many shares as you want.
  • "10 hours ago - BidaskClub upgraded shares of Insmed, Inc." Wow!
  • From a different venue,a different opinion "if the results are good but market place application questionable,Insmed may partner. Partnership deals almost always have money up front with additional money contingent on the drugs success. The larger owner limits their exposure to losses yet is positioned to take over the company with market success.Partnership upfront cash usually defers any offering for a couple of years.From a trading perspective a strong partner is imho as good as a takeover in terms of price appreciation and would set up positioning trades into the future "
  • I must say, this has pump & dump written all over it. So don't sell just yet, wait for the dump. Whenever you see headlines like this "Analyst Neena M. Bitritto-Garg commented, "We're buyers heading into the Phase 3 CONVERT readout for Insmed's lead asset", or this " Leerink analyst Joseph Schwartz raised his price target for Insmed to $27 from $21 to reflect Q1 net income/EPS and management's current estimates for the..." Learn how to spot a p&d and you can make some easy money in both directions. As I said before, they only have about 90 days of cash left. They need to hire a regulatory person to compile and submit data to the CMC https://www.ziprecruiter.com/jobs/insmed-incorporated-d8e6590e/senior-director-regulatory-cmc-73d93c49 Must successfully exhibit Insmed's five (5) core corporate competencies of: Excellence, Accountability, Driven, Collaborative and Solutions; along with any other position specific competencies.

    Insmed Incorporated Senior Director, Regulatory CMC Job in Bridgewater NJ
    Job DescriptionSUMMARY:Overall responsibility for providing CMC Regulatory oversight & strategic technical regulatory input across all project activities to ensure CMC regulatory